“In-silico Studies of Heterocyclic Benzoxazole Derivatives as an Anticancer Agent: Molecular Docking, 2D and 3D QSAR ” (2023) International Journal of Pharmaceutical Sciences and Drug Research, 15(6), pp. 780–788. doi:10.25004/IJPSDR.2023.150612.